Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-14-067297)

Filing Details

Accession Number:: 0001144204-14-067297
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-11-12 17:19:16
Reporting Period:: 2014-11-12

Filing Date:: 2014-11-12
Accepted Time:: 2014-11-12 17:19:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
897075	Repros Therapeutics Inc.	RPRX	Biological Products, (No Disgnostic Substances) (2836)	760233274

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1476301	Katherine Anderson	2408 Timberloch Place, B-7 The Woodlands TX 77380	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-11-12	3,500	$9.41	11,875	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents the weighted average of a range of purchase prices per share from $9.40 to $9.46. The reporting person undertakes to provide to the Staff of the Securities and Exchange Commission, the Company or any shareholder of the Company, upon request, full information regarding the number of shares purchased at each separate price.